AcelRx Pharmaceuticals, Inc. (ACRX) Social Stream
ACELRX PHARMACEUTICALS INC (ACRX) Price Targets From Analysts
Use the tables below to see what analysts covering ACELRX PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
ACRX reports an average of 5,005.12% for its upside potential over the past 36 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ACRX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 13 months, ACRX's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, ACELRX PHARMACEUTICALS INC's number of analysts covering the stock is higher than 37.11% of them.
- ACELRX PHARMACEUTICALS INC's average analyst price target is greater than 84.88% of all US stocks.
- ACRX has a lower variance in analysts' estimates than -53.23% of Healthcare stocks.
- In terms of how ACELRX PHARMACEUTICALS INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 320.79% of that group.
In the Pharmaceutical Products industry, ASMB, KURA, and IBIO are the three stocks most similar to ACELRX PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
What is the outlook for ACRX? Use POWR Ratings for clearer insight into price direction.